Streetbeat News

Price Targets

CI

Raymond James analyst John Ransom maintains a Strong Buy rating on Cigna Group (NYSE:CI) and raises the price target from $310 to $330.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:24 am

TFX

Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on Teleflex (NYSE:TFX), but lowered the price target from $272 to $255.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:23 am

QTWO

Canaccord Genuity analyst Joseph Vafi has upgraded Q2 Holdings (NYSE:QTWO) from Hold to Buy and raised the price target from $25 to $40.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:20 am

SQ

Canaccord Genuity analyst Joseph Vafi has reiterated a 'Buy' rating on Block (NYSE:SQ) and maintained a price target of $90.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:17 am

SPT

Piper Sandler analyst Clarke Jeffries has reiterated an Overweight rating on Sprout Social (NASDAQ:SPT) and maintained a price target of $56.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:11 am

BIGC

Piper Sandler analyst Clarke Jeffries maintains a Neutral rating on BigCommerce Holdings (NASDAQ:BIGC) and raises the price target from $9 to $11.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:11 am

SEMR

Piper Sandler analyst Clarke Jeffries maintains an Overweight rating on SEMrush Hldgs (NYSE:SEMR) and raises the price target from $10 to $12.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:10 am

SAGE

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Sage Therapeutics (NASDAQ:SAGE) and maintained a $70 price target.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:09 am

SEMR

Needham analyst Scott Berg has reiterated a 'Buy' rating on SEMrush Hldgs (NYSE:SEMR) and maintained a price target of $13.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:02 am

DKNG

Needham analyst Bernie McTernan maintains a Buy rating on DraftKings (NASDAQ:DKNG) and raises the price target from $36 to $44.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 8:01 am